Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Petra Acquisition (PAICW)

Petra Acquisition Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PAICW
DateTimeSourceHeadlineSymbolCompany
22/12/202114:00GlobeNewswire Inc.Petra Acquisition, Inc. Announces Share Redemption Backstop and Forward Purchase Agreements in Connection with Revelation Biosciences, Inc. Business CombinationNASDAQ:PAICWPetra Acquisition Inc
16/12/202121:15GlobeNewswire Inc.Petra Acquisition, Inc. Announces Special Meeting of Stockholders to Approve Business Combination with Revelation Biosciences, Inc.NASDAQ:PAICWPetra Acquisition Inc
06/12/202121:01GlobeNewswire Inc.Revelation Biosciences Inc. Appoints Joseph A. Bellanti, M.D. to Scientific Advisory BoardNASDAQ:PAICWPetra Acquisition Inc
01/12/202121:01GlobeNewswire Inc.Revelation Biosciences Inc. Announces Initiation of a Phase 2b Study to Assess Efficacy of Intranasal REVTx-99 for The Prevention of H3N2 InfluenzaNASDAQ:PAICWPetra Acquisition Inc
29/11/202114:00GlobeNewswire Inc.Revelation Biosciences Inc. Announces Creation and Appointments to Scientific Advisory BoardNASDAQ:PAICWPetra Acquisition Inc
15/11/202114:00GlobeNewswire Inc.Revelation Biosciences Inc. Announces Initiation of a Phase 1b Clinical Study of REVTx-99 for the Experimental Treatment of Allergic Rhinitis and Chronic Nasal CongestionNASDAQ:PAICWPetra Acquisition Inc
01/11/202113:00GlobeNewswire Inc.Revelation Biosciences Inc. Engages Partnering Advisor, MedWorld Advisors, to Optimize Value of the Company’s Diagnostic Tool, REVID™NASDAQ:PAICWPetra Acquisition Inc
25/10/202121:01GlobeNewswire Inc.Revelation Biosciences Inc. Engages Destum Partners Inc. to Identify Strategic Partners for REVTx-99 (Ex-US) and REVTx-200 (Worldwide)NASDAQ:PAICWPetra Acquisition Inc
04/10/202114:00GlobeNewswire Inc.Revelation Biosciences Inc. Receives Approval to Begin a Phase 1b Clinical Study of REVTx-99 as an Experimental Treatment for Allergic Rhinitis and Chronic Nasal CongestionNASDAQ:PAICWPetra Acquisition Inc
28/09/202114:00GlobeNewswire Inc.Revelation Biosciences Inc. Receives Approval to Initiate Phase 2b Viral Challenge Study of REVTx 99, an Experimental Prophylactic Treatment for the Prevention of Respiratory Viral InfectionsNASDAQ:PAICWPetra Acquisition Inc
30/08/202111:00Business WireRevelation Biosciences, Inc., a Life Sciences Company Developing Therapeutics and Diagnostics for Respiratory Viral Infections, Including COVID-19, to Become Publicly Traded Through a Merger with Petra Acquisition, Inc.NASDAQ:PAICWPetra Acquisition Inc
 Showing the most relevant articles for your search:NASDAQ:PAICW

Your Recent History

Delayed Upgrade Clock